StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report published on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 1.6 % Shares of NYSE:BTX opened at $0.90 on Tuesday. The firm’s 50 day moving average is $1.59 and its two-hundred day moving average […]